Product Information
METHYLPHENIDATE 5 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.1344 per EA under NDC 75834032401. Its NADAC has been published 86 times since Nov 6, 2024.
Strength
5 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834032401
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208737On Market Since
4/16/2024
Pharmacological Classes
Price Statistics
The NADAC for METHYLPHENIDATE 5 MG TABLET has been published 86 times since Nov 6, 2024, and over the history we have for it it has declined 2.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1344 per EA |
|---|---|
| All-time high | $0.1434 (Feb 11, 2026) |
| All-time low | $0.1071 (Nov 20, 2024) |
| 52-week high | $0.1434 |
| 52-week low | $0.1344 |
| Median price | $0.1361 |
| Average price | $0.1331 |
| Largest weekly change | -22.4% (Nov 20, 2024) |
| Weeks tracked | 86 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHYLPHENIDATE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE 5 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.1344 per EA (NDC 75834032401), effective Jun 24, 2026.
How has the price of METHYLPHENIDATE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLPHENIDATE 5 MG TABLET has declined 2.6%. It has been tracked across 86 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE 5 MG TABLET?
Since Nov 6, 2024, the NADAC for METHYLPHENIDATE 5 MG TABLET has ranged from a low of $0.1071 (Nov 20, 2024) to a high of $0.1434 (Feb 11, 2026), with a median of $0.1361 per EA.
Are there cheaper alternatives to METHYLPHENIDATE 5 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as METHYLPHENIDATE 5 MG TABLET, but none are currently priced below it.
Who manufactures METHYLPHENIDATE 5 MG TABLET?
METHYLPHENIDATE 5 MG TABLET (NDC 75834032401) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification